Alpha Paradigm Partners, LLC Eli Lilly & CO Transaction History
Alpha Paradigm Partners, LLC
- $239 Million
- Q4 2022
A detailed history of Alpha Paradigm Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Alpha Paradigm Partners, LLC holds 221 shares of LLY stock, worth $192,926. This represents 0.03% of its overall portfolio holdings.
Number of Shares
221
Previous 93
137.63%
Holding current value
$192,926
Previous $30,000
166.67%
% of portfolio
0.03%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
4,159Shares Held
750MCall Options Held
8.4MPut Options Held
10.2M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$84.6 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$64.8 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$57.5 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$44.8 Billion26.72% of portfolio
-
State Street Corp Boston, MA33.9MShares$29.6 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $829B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...